ICLR
ICON Public Limited Company
Price Chart
Latest Quote
$158.17
+15.50 (+10.86%)
Current Price
| Previous Close | $142.67 |
| Open | $147.79 |
| Day High | $161.92 |
| Day Low | $147.71 |
| Volume | 2,406,383 |
Stock Information
| Shares Outstanding | 76.60M |
| Total Debt | $3.56B |
| Cash Equivalents | $647.29M |
| Revenue | $8.25B |
| Net Income | $229.34M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $12.12B |
| P/E Ratio | 69.68 |
| EPS (TTM) | $2.27 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $13.83B |
| Sales | $8.25B |
| Income | $229.34M |
| Book/sh | $120.07 |
| Cash/sh | $8.45 |
| Employees | 40K |
Financial Ratios
| Quick Ratio | 1.06 |
| Current Ratio | 1.10 |
| Debt/Eq | 38.68 |
Returns & Margins
| ROA | 3.85% |
| ROE | 2.46% |
| Gross Margin | 26.44% |
| Operating Margin | 10.52% |
| Profit Margin | 2.78% |
Ownership
| Insider Ownership | 0.44% |
| Institutional Ownership | 108.98% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 13.52 |
| PEG | 0.47 |
| P/S | 1.47 |
| P/B | 1.32 |
Analyst Data
| Recommendation | buy |
| Target Price | $154.81 |
Technical Indicators
| SMA20 | $143.99 |
| SMA50 | $126.85 |
| SMA200 | $149.26 |
| RSI | 61.29 |
| ATR | 7.5557 |
| Shares Float | 76.23M |
| Short Float | 3.95% |
| Short Ratio | 2.45 |
| Volatility | 1.27 |
| Rel Volume | 1.88 |
Performance History
| Week | +10.19% |
| Month | +35.44% |
| Quarter | +56.17% |
| 6 Months | -8.98% |
| YTD | -16.17% |
| Year | +7.38% |
| 3 Years | -32.44% |
| 5 Years | -24.88% |
| 10 Years | +140.67% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $158.17 | 2,406,500 |
| 2026-06-23 | $142.67 | 696,200 |
| 2026-06-22 | $140.73 | 918,700 |
| 2026-06-18 | $146.00 | 870,100 |
| 2026-06-17 | $143.27 | 989,800 |
| 2026-06-16 | $143.54 | 568,500 |
| 2026-06-15 | $147.72 | 598,000 |
| 2026-06-12 | $146.18 | 703,900 |
| 2026-06-11 | $149.92 | 790,300 |
| 2026-06-10 | $144.59 | 1,014,500 |
| 2026-06-09 | $151.82 | 1,220,500 |
| 2026-06-08 | $152.24 | 1,129,000 |
| 2026-06-05 | $149.45 | 1,348,900 |
| 2026-06-04 | $152.80 | 1,689,900 |
| 2026-06-03 | $143.90 | 1,380,500 |
| 2026-06-02 | $137.54 | 1,244,100 |
| 2026-06-01 | $138.03 | 1,308,100 |
| 2026-05-29 | $136.07 | 1,581,300 |
| 2026-05-28 | $136.80 | 3,417,900 |
| 2026-05-27 | $118.45 | 1,760,000 |
| 2026-05-26 | $113.85 | 996,400 |
About ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
đ° Latest News
Why Icon Stock Crushed it on Wednesday
Motley Fool âĸ 2026-06-24T21:22:33Z
Icon PLC (ICLR) Q1 2026 Earnings Call Highlights: Strong Bookings and Strategic Expansions Amid ...
GuruFocus.com âĸ 2026-06-24T19:00:48ZGreenskeeper Asset Management Increased Its Holdings in ICON Plc (ICLR) Amid Market Fear
Insider Monkey âĸ 2026-06-15T13:29:54Z
The Cooper Companies (COO) Beats Q2 Earnings and Revenue Estimates
Zacks âĸ 2026-06-04T21:45:01Z
ICON (ICLR) Is Up 20.8% After 2026 Outlook, Buyback And Governance Shake-Up - Has The Bull Case Changed?
Simply Wall St. âĸ 2026-06-03T16:07:39Z
McIntyre Partnerships Sold Its Position in ICON Public Limited Company (ICLR). Hereâs Why
Insider Monkey âĸ 2026-06-01T16:36:40Z
Grindr Stock Is Down 49%. Here's Why One Investor Added $15.9 Million
Motley Fool âĸ 2026-05-30T18:04:52Z
ICON Public Limited Company Q4 2025 Earnings Call Summary
Moby âĸ 2026-05-29T12:30:00Z
Icon PLC (ICLR) Q4 2025 Earnings Call Highlights: Strong Bookings Amid Revenue Challenges
GuruFocus.com âĸ 2026-05-28T23:02:51ZIcon Q4 Earnings Call Highlights
MarketBeat âĸ 2026-05-28T14:10:36Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,075,746,000 | $5,818,061,000 | $5,706,187,000 | $5,527,045,000 |
| Cost Of Revenue | $6,075,746,000 | $5,818,061,000 | $5,706,187,000 | $5,527,045,000 |
| Total Revenue | $8,251,340,000 | $8,188,990,000 | $8,054,926,000 | $7,741,386,000 |
| Operating Revenue | $8,251,340,000 | $8,188,990,000 | $8,054,926,000 | $7,741,386,000 |
| Expenses | ||||
| Interest Expense | $188,109,000 | $206,198,000 | $311,019,000 | $209,189,000 |
| Total Expenses | $7,238,881,000 | $7,034,909,000 | $7,060,696,000 | $6,875,311,000 |
| Other Income Expense | $-569,613,000 | $-121,697,000 | $-89,566,000 | $-70,838,000 |
| Net Non Operating Interest Income Expense | $-190,381,000 | $-228,628,000 | $-331,685,000 | $-227,386,000 |
| Total Other Finance Cost | $9,381,000 | $31,039,000 | $25,680,000 | $20,542,000 |
| Interest Expense Non Operating | $188,109,000 | $206,198,000 | $311,019,000 | $209,189,000 |
| Operating Expense | $1,163,135,000 | $1,216,848,000 | $1,354,509,000 | $1,348,266,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $229,339,000 | $739,126,000 | $554,208,000 | $505,304,000 |
| Net Interest Income | $-190,381,000 | $-228,628,000 | $-331,685,000 | $-227,386,000 |
| Interest Income | $7,109,000 | $8,609,000 | $5,014,000 | $2,345,000 |
| Normalized Income | $746,547,604 | $851,037,347 | $640,899,655 | $568,730,626 |
| Net Income From Continuing And Discontinued Operation | $229,339,000 | $739,126,000 | $554,208,000 | $505,304,000 |
| Total Operating Income As Reported | $442,846,000 | $1,032,384,000 | $904,664,000 | $795,237,000 |
| Net Income Common Stockholders | $229,339,000 | $739,126,000 | $554,208,000 | $505,304,000 |
| Net Income | $229,339,000 | $739,126,000 | $554,208,000 | $505,304,000 |
| Net Income Including Noncontrolling Interests | $229,339,000 | $739,126,000 | $554,208,000 | $505,304,000 |
| Net Income Continuous Operations | $229,339,000 | $739,126,000 | $554,208,000 | $505,304,000 |
| Earnings From Equity Interest Net Of Tax | $0 | $0 | $-383,000 | $-3,136,000 |
| Pretax Income | $252,465,000 | $803,756,000 | $572,979,000 | $567,851,000 |
| Special Income Charges | $-569,613,000 | $-121,697,000 | $-89,566,000 | $-70,838,000 |
| Interest Income Non Operating | $7,109,000 | $8,609,000 | $5,014,000 | $2,345,000 |
| Operating Income | $1,012,459,000 | $1,154,081,000 | $994,230,000 | $866,075,000 |
| Depreciation Amortization Depletion Income Statement | $382,996,000 | $488,500,000 | $585,950,000 | $569,513,000 |
| Depreciation And Amortization In Income Statement | $382,996,000 | $488,500,000 | $585,950,000 | $569,513,000 |
| Amortization Of Intangibles Income Statement | $227,220,000 | $350,291,000 | $459,854,000 | - |
| Depreciation Income Statement | $155,776,000 | $138,209,000 | $126,096,000 | - |
| Gross Profit | $2,175,594,000 | $2,370,929,000 | $2,348,739,000 | $2,214,341,000 |
| Per Share | ||||
| Diluted EPS | $2.90 | $8.90 | $6.70 | $6.13 |
| Basic EPS | $2.92 | $8.96 | $6.75 | $6.21 |
| Other | ||||
| Tax Effect Of Unusual Items | $-52,404,396 | $-9,785,653 | $-2,874,345 | $-7,411,374 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,393,183,000 | $1,620,151,000 | $1,559,514,000 | $1,417,391,000 |
| Total Unusual Items | $-569,613,000 | $-121,697,000 | $-89,566,000 | $-70,838,000 |
| Total Unusual Items Excluding Goodwill | $-569,613,000 | $-121,697,000 | $-89,566,000 | $-70,838,000 |
| Reconciled Depreciation | $382,996,000 | $488,500,000 | $585,950,000 | $569,513,000 |
| EBITDA (Bullshit earnings) | $823,570,000 | $1,498,454,000 | $1,469,948,000 | $1,346,553,000 |
| EBIT | $440,574,000 | $1,009,954,000 | $883,998,000 | $777,040,000 |
| Diluted Average Shares | $78,965,385 | $83,032,424 | $82,717,640 | $82,536,826 |
| Basic Average Shares | $78,423,675 | $82,482,764 | $82,101,813 | $81,532,320 |
| Diluted NI Availto Com Stockholders | $229,339,000 | $739,126,000 | $554,208,000 | $505,304,000 |
| Tax Provision | $23,126,000 | $64,630,000 | $18,388,000 | $59,411,000 |
| Impairment Of Capital Assets | $465,275,000 | $0 | $0 | - |
| Restructuring And Mergern Acquisition | $104,338,000 | $121,697,000 | $89,566,000 | $70,838,000 |
| Amortization | $227,220,000 | $350,291,000 | $459,854,000 | - |
| Selling General And Administration | $780,139,000 | $728,348,000 | $768,559,000 | $778,753,000 |
| Minority Interests | - | - | - | $0 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-2,785,423,000 | $-3,169,848,000 | $-3,666,494,000 | $-4,752,366,000 |
| Total Assets | $16,269,782,000 | $16,634,822,000 | $16,864,783,000 | $17,185,278,000 |
| Total Non Current Assets | $12,768,107,000 | $13,348,259,000 | $13,577,586,000 | $13,956,212,000 |
| Non Current Deferred Assets | $106,871,000 | $75,832,000 | $72,855,000 | $76,930,000 |
| Non Current Deferred Taxes Assets | $106,871,000 | $75,832,000 | $72,855,000 | $76,930,000 |
| Non Current Accounts Receivable | $75,707,000 | $72,796,000 | $78,470,000 | $92,170,000 |
| Goodwill And Other Intangible Assets | $11,978,807,000 | $12,611,202,000 | $12,877,940,000 | $13,250,329,000 |
| Other Intangible Assets | $3,247,118,000 | $3,559,792,000 | $3,855,865,000 | $4,278,659,000 |
| Current Assets | $3,501,675,000 | $3,275,168,000 | $3,287,197,000 | $3,229,066,000 |
| Other Current Assets | $105,316,000 | $140,435,000 | $132,105,000 | $137,094,000 |
| Receivables | $2,749,064,000 | $2,595,948,000 | $2,775,036,000 | $2,801,491,000 |
| Other Receivables | $1,213,342,000 | $1,119,661,000 | $919,378,000 | $1,021,313,000 |
| Taxes Receivable | $60,824,000 | $83,523,000 | $91,254,000 | $48,790,000 |
| Accounts Receivable | $1,474,898,000 | $1,392,764,000 | $1,764,404,000 | $1,731,388,000 |
| Allowance For Doubtful Accounts Receivable | $-42,319,000 | $-35,664,000 | $-31,533,000 | $-20,562,000 |
| Gross Accounts Receivable | $1,517,217,000 | $1,428,428,000 | $1,795,937,000 | $1,751,950,000 |
| Cash Cash Equivalents And Short Term Investments | $647,295,000 | $538,785,000 | $380,056,000 | $290,481,000 |
| Cash And Cash Equivalents | $647,295,000 | $538,785,000 | $378,102,000 | $288,768,000 |
| Investmentin Financial Assets | - | - | $46,804,000 | $32,631,000 |
| Other Non Current Assets | - | - | - | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $2,755,083,000 | $2,887,375,000 | $3,397,487,000 | $4,365,419,000 |
| Total Debt | $3,555,782,000 | $3,603,028,000 | $3,938,324,000 | $4,829,488,000 |
| Long Term Debt And Capital Lease Obligation | $2,989,738,000 | $3,536,483,000 | $3,791,760,000 | $4,730,681,000 |
| Long Term Debt | $2,872,616,000 | $3,396,398,000 | $3,665,439,000 | $4,599,037,000 |
| Current Debt And Capital Lease Obligation | $566,044,000 | $66,545,000 | $146,564,000 | $98,807,000 |
| Current Debt | $529,762,000 | $29,762,000 | $110,150,000 | $55,150,000 |
| Other Current Borrowings | $529,762,000 | $29,762,000 | $110,150,000 | $55,150,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,076,398,000 | $7,193,468,000 | $7,653,337,000 | $8,687,315,000 |
| Total Non Current Liabilities Net Minority Interest | $3,880,223,000 | $4,557,976,000 | $4,923,020,000 | $5,996,714,000 |
| Other Non Current Liabilities | $72,807,000 | $82,718,000 | $45,246,000 | $25,227,000 |
| Tradeand Other Payables Non Current | $103,251,000 | $127,544,000 | $187,706,000 | $239,188,000 |
| Non Current Deferred Liabilities | $714,427,000 | $811,231,000 | $898,308,000 | $988,585,000 |
| Non Current Deferred Taxes Liabilities | $714,427,000 | $811,231,000 | $898,308,000 | $988,585,000 |
| Current Liabilities | $3,196,175,000 | $2,635,492,000 | $2,730,317,000 | $2,690,601,000 |
| Other Current Liabilities | $39,514,000 | $129,397,000 | $29,561,000 | $35,260,000 |
| Current Deferred Liabilities | $1,550,546,000 | $1,467,712,000 | $1,566,507,000 | $1,507,491,000 |
| Payables And Accrued Expenses | $799,849,000 | $753,264,000 | $609,434,000 | $653,181,000 |
| Payables | $799,849,000 | $753,264,000 | $609,434,000 | $653,181,000 |
| Total Tax Payable | $18,999,000 | $55,258,000 | $13,968,000 | $41,783,000 |
| Income Tax Payable | $18,999,000 | $55,258,000 | $13,968,000 | $41,783,000 |
| Accounts Payable | $780,850,000 | $698,006,000 | $595,466,000 | $611,398,000 |
| Equity | ||||
| Common Stock Equity | $9,193,384,000 | $9,441,354,000 | $9,211,446,000 | $8,497,963,000 |
| Total Equity Gross Minority Interest | $9,193,384,000 | $9,441,354,000 | $9,211,446,000 | $8,497,963,000 |
| Stockholders Equity | $9,193,384,000 | $9,441,354,000 | $9,211,446,000 | $8,497,963,000 |
| Other Equity Interest | $1,606,000 | $1,304,000 | $1,162,000 | $1,162,000 |
| Gains Losses Not Affecting Retained Earnings | $-68,534,000 | $-229,929,000 | $-143,506,000 | $-171,538,000 |
| Other Equity Adjustments | $-68,534,000 | $-229,929,000 | $-143,506,000 | $-171,538,000 |
| Retained Earnings | $2,122,051,000 | $2,643,162,000 | $2,404,422,000 | $1,821,384,000 |
| Long Term Equity Investment | $82,050,000 | $57,948,000 | $46,804,000 | $32,631,000 |
| Other | ||||
| Ordinary Shares Number | $76,567,325 | $80,756,860 | $82,495,086 | $81,723,555 |
| Share Issued | $76,567,325 | $80,756,860 | $82,495,086 | $81,723,555 |
| Tangible Book Value | $-2,785,423,000 | $-3,169,848,000 | $-3,666,494,000 | $-4,752,366,000 |
| Invested Capital | $12,595,762,000 | $12,867,514,000 | $12,987,035,000 | $13,152,150,000 |
| Working Capital | $305,500,000 | $639,676,000 | $556,880,000 | $538,465,000 |
| Capital Lease Obligations | $153,404,000 | $176,868,000 | $162,735,000 | $175,301,000 |
| Total Capitalization | $12,066,000,000 | $12,837,752,000 | $12,876,885,000 | $13,097,000,000 |
| Additional Paid In Capital | $7,131,956,000 | $7,020,231,000 | $6,942,669,000 | $6,840,306,000 |
| Capital Stock | $6,305,000 | $6,586,000 | $6,699,000 | $6,649,000 |
| Common Stock | $6,305,000 | $6,586,000 | $6,699,000 | $6,649,000 |
| Long Term Capital Lease Obligation | $117,122,000 | $140,085,000 | $126,321,000 | $131,644,000 |
| Current Deferred Revenue | $1,550,546,000 | $1,467,712,000 | $1,566,507,000 | $1,507,491,000 |
| Current Capital Lease Obligation | $36,282,000 | $36,783,000 | $36,414,000 | $43,657,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $240,222,000 | $218,574,000 | $378,251,000 | $395,862,000 |
| Investments And Advances | $82,050,000 | $57,948,000 | $46,804,000 | $32,631,000 |
| Goodwill | $8,731,689,000 | $9,051,410,000 | $9,022,075,000 | $8,971,670,000 |
| Net PPE | $524,672,000 | $530,481,000 | $501,517,000 | $504,152,000 |
| Accumulated Depreciation | $-703,466,000 | $-546,015,000 | $-419,883,000 | $-400,173,000 |
| Gross PPE | $1,228,138,000 | $1,076,496,000 | $921,400,000 | $904,325,000 |
| Leases | $72,275,000 | $62,034,000 | $55,000,000 | $65,167,000 |
| Other Properties | $190,599,000 | $202,713,000 | $196,550,000 | $213,778,000 |
| Machinery Furniture Equipment | $878,271,000 | $741,893,000 | $596,054,000 | $550,776,000 |
| Buildings And Improvements | $83,269,000 | $66,132,000 | $70,072,000 | $70,880,000 |
| Land And Improvements | $3,724,000 | $3,724,000 | $3,724,000 | $3,724,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $0 | $0 | $1,954,000 | $1,713,000 |
| Employee Benefits | - | - | $14,738,000 | $13,033,000 |
| Non Current Pension And Other Postretirement Benefit Plans | - | - | $14,738,000 | $13,033,000 |
| Available For Sale Securities | - | - | $46,804,000 | $32,631,000 |
| Current Accrued Expenses | - | - | - | $406,300,000 |
| Non Current Deferred Revenue | - | - | - | - |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $861,991,000 | $1,118,592,000 | $1,020,335,000 | $421,155,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,036,205,000 | $1,286,652,000 | $1,161,027,000 | $563,315,000 |
| Cash Flow From Continuing Operating Activities | $1,036,205,000 | $1,286,652,000 | $1,161,027,000 | $563,315,000 |
| Operating Gains Losses | $26,464,000 | $6,911,000 | $20,089,000 | $-9,873,000 |
| Investing Activities | ||||
| Capital Expenditure | $-174,214,000 | $-168,060,000 | $-140,692,000 | $-142,160,000 |
| Investing Cash Flow | $-187,533,000 | $-266,790,000 | $-226,653,000 | $-145,867,000 |
| Cash Flow From Continuing Investing Activities | $-187,533,000 | $-266,790,000 | $-226,653,000 | $-145,867,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-750,000,000 | $-499,998,000 | $0 | $-99,983,000 |
| Financing Cash Flow | $-771,257,000 | $-837,183,000 | $-844,043,000 | $-864,173,000 |
| Cash Flow From Continuing Financing Activities | $-771,257,000 | $-837,183,000 | $-844,043,000 | $-864,173,000 |
| Net Other Financing Charges | $-1,219,000 | $-13,089,000 | $-16,000 | $-34,000 |
| Net Common Stock Issuance | $-750,000,000 | $-499,998,000 | $0 | $-99,983,000 |
| Other | ||||
| Repayment Of Debt | $-79,762,000 | $-2,677,763,000 | $-1,265,000,000 | $-875,000,000 |
| Issuance Of Debt | $50,000,000 | $2,317,480,000 | $370,000,000 | $75,000,000 |
| End Cash Position | $647,295,000 | $538,785,000 | $378,102,000 | $288,768,000 |
| Beginning Cash Position | $538,785,000 | $378,102,000 | $288,768,000 | $752,213,000 |
| Effect Of Exchange Rate Changes | $31,095,000 | $-21,996,000 | $-997,000 | $-16,720,000 |
| Changes In Cash | $77,415,000 | $182,679,000 | $90,331,000 | $-446,725,000 |
| Proceeds From Stock Option Exercised | $9,724,000 | $36,187,000 | $50,973,000 | $35,844,000 |
| Common Stock Payments | $-750,000,000 | $-499,998,000 | $0 | $-99,983,000 |
| Net Issuance Payments Of Debt | $-29,762,000 | $-360,283,000 | $-895,000,000 | $-800,000,000 |
| Net Long Term Debt Issuance | $-29,762,000 | $-360,283,000 | $-895,000,000 | $-800,000,000 |
| Long Term Debt Payments | $-79,762,000 | $-2,677,763,000 | $-1,265,000,000 | $-875,000,000 |
| Long Term Debt Issuance | $50,000,000 | $2,317,480,000 | $370,000,000 | $75,000,000 |
| Net Investment Purchase And Sale | $-10,782,000 | $-14,571,000 | $-14,195,000 | $-3,707,000 |
| Sale Of Investment | $9,089,000 | $2,690,000 | $0 | $1,906,000 |
| Purchase Of Investment | $-19,871,000 | $-17,261,000 | $-14,195,000 | $-5,613,000 |
| Net Business Purchase And Sale | $-2,537,000 | $-84,159,000 | $-71,766,000 | $0 |
| Purchase Of Business | $-2,537,000 | $-84,159,000 | $-71,766,000 | $0 |
| Net PPE Purchase And Sale | $-174,214,000 | $-168,060,000 | $-140,692,000 | $-142,160,000 |
| Purchase Of PPE | $-174,214,000 | $-168,060,000 | $-140,692,000 | $-142,160,000 |
| Change In Working Capital | $-98,103,000 | $-1,820,000 | $-54,305,000 | $-550,222,000 |
| Change In Other Working Capital | $68,516,000 | $-96,787,000 | $46,523,000 | $192,944,000 |
| Change In Other Current Assets | $2,703,000 | $-45,473,000 | $-161,778,000 | $10,121,000 |
| Change In Receivables | $-169,322,000 | $140,440,000 | $60,950,000 | $-753,287,000 |
| Changes In Account Receivables | $-108,213,000 | $332,616,000 | $-57,378,000 | $-420,695,000 |
| Other Non Cash Items | $53,429,000 | $95,220,000 | $76,120,000 | $74,288,000 |
| Stock Based Compensation | $102,041,000 | $45,870,000 | $55,667,000 | $70,523,000 |
| Asset Impairment Charge | $468,958,000 | $15,731,000 | $8,686,000 | $28,767,000 |
| Deferred Tax | $-128,919,000 | $-102,886,000 | $-85,388,000 | $-124,985,000 |
| Deferred Income Tax | $-128,919,000 | $-102,886,000 | $-85,388,000 | $-124,985,000 |
| Depreciation Amortization Depletion | $382,996,000 | $488,500,000 | $585,950,000 | $569,513,000 |
| Depreciation And Amortization | $382,996,000 | $488,500,000 | $585,950,000 | $569,513,000 |
| Earnings Losses From Equity Investments | $0 | $0 | $383,000 | $3,136,000 |
| Net Foreign Currency Exchange Gain Loss | $26,464,000 | $6,911,000 | $19,706,000 | $-13,009,000 |
| Net Income From Continuing Operations | $229,339,000 | $739,126,000 | $554,208,000 | $505,304,000 |
| Interest Paid Supplemental Data | - | - | $317,975,000 | $210,918,000 |
| Income Tax Paid Supplemental Data | - | - | $163,778,000 | $116,322,000 |
| Gain Loss On Investment Securities | - | - | $2,407,000 | - |
| Amortization Cash Flow | - | - | - | $463,087,000 |
| Amortization Of Intangibles | - | - | - | $463,087,000 |
| Depreciation | - | - | - | $106,426,000 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-20